Active ingredientOxonic Acid Potassium SaltCat. No. P-O065-001CAS 2207-75-2Family · Pharmaceutical analytical standards
Oxonic Acid
A triazine derivative that inhibits certain metabolic enzymes. As its potassium salt (oteracil) it is part of an oral anticancer combination with tegafur and gimeracil, approved in Europe in 2011, in which it stays in the gut and reduces side effects. This family brings together the active ingredient and other impurities.
Did you know?It blocks uricase, the enzyme that breaks down uric acid in most other mammals but is missing in humans: that is why researchers give it to mice and rats to study gout in the laboratory.
Go to the active ingredient →Active ingredientOxonic Acid Potassium SaltCat. No. P-O065-001CAS 2207-75-2
Impurity1,3,5-triazine-2,4(1H,3H)-dioneCat. No. P-O065-003CAS 71-33-0
Impurity4-amino-1H-imidazole-2,5-dioneCat. No. P-O065-004CAS 60301-55-5No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.